Detalus Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Detalus Advisors's AMGN Position: Q2 2026 in Review
Detalus Advisors reduced its Amgen (AMGN) stake by 18% in Q2 2026, selling an estimated $69.1K and leaving 897 shares worth $325K. The position accounts for 0.06% of the portfolio, ranked #141.
Detalus Advisors first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $577K in Q1 2021. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Detalus Advisors held 897 shares of Amgen worth $325K as of Q2 2026.
- Detalus Advisors sold 202 Amgen shares in Q2 2026, an estimated $69.1K.
- Amgen made up 0.06% of Detalus Advisors's portfolio in Q2 2026, its #141 holding.
- Detalus Advisors first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- Detalus Advisors's Amgen position peaked at $577K in Q1 2021.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Detalus Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.